サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1352942

ホルモン補充療法の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測

Global Hormone Replacement Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 177 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ホルモン補充療法の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測
出版日: 2023年09月01日
発行: Value Market Research
ページ情報: 英文 177 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ホルモン補充療法市場の世界需要は、2022年の236億8,000万米ドルから2030年には455億5,000万米ドル近くの市場規模に達すると推定され、調査期間2023～2030年のCAGRは8.52%です。

ホルモン補充療法（HRT）は、更年期障害に悩む女性の治療に用いられる療法です。このような更年期障害患者のホルモン量は、人体の正常な生理機能に必要な量に比べて不十分です。ホルモン補充療法は、閉経時に開始されたものであれ、それ以降に開始されたものであれ、多くの高齢女性の生活を改善し、延命させる。ホルモン補充療法は、高齢女性がエストロゲンレベルを維持するのに役立ちます。

市場力学：

更年期の不快感の急増と閉経後の問題に対する女性の意識の高まりが、ホルモン補充療法市場の成長に大きく影響すると予想されます。老年人口の増加も、この治療法の需要が高い理由です。これとともに、新しいホルモン補充療法製品の発売が市場の成長を促進すると予想されます。さらに、ドラッグデリバリーシステムの技術革新も、今後数年間はホルモン補充療法市場にプラスの影響を与える可能性があります。さらに、ホルモン補充療法に関する認知度の向上も市場成長の原動力になると予想されます。しかし、ホルモン補充療法治療に伴う高価格が市場成長の妨げになる可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、ホルモン補充療法の世界市場における各セグメントを包括的に評価することもできます。ホルモン補充療法産業の成長と動向は、この研究に全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるホルモン補充療法市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における各用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 ホルモン補充療法：産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 ホルモン補充療法の世界市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • エストロゲン・プロゲステロン補充療法
  • ヒト成長ホルモン（HGH）補充療法
  • 甲状腺ホルモン補充療法
  • 男性ホルモン補充療法
  • 副甲状腺ホルモン補充療法

第7章 ホルモン補充療法の世界市場分析：投与経路別

  • 投与経路別概要
  • 実績データと予測データ
  • 投与経路別分析
  • 経口
  • 非経口
  • 経皮
  • その他

第8章 ホルモン補充療法の世界市場売上高分析：疾患タイプ別

  • 疾患タイプ別概要
  • 実績データと予測データ
  • 疾患タイプ別分析
  • 更年期障害
  • 甲状腺機能低下症
  • 男性性腺機能低下症
  • 成長ホルモン欠乏症
  • 副甲状腺機能低下症

第9章 ホルモン補充療法の世界市場売上分析：地域別

  • 地域別展望販売分析
  • イントロダクション売上分析
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東とアフリカ

第10章 ホルモン補充療法企業の競合情勢

  • ホルモン補充療法市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第11章 企業プロファイル

  • 上位10社のシェア分析
  • 市場集中度
  • Bayer AG
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Viatris Inc.
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Noven Pharmaceuticals Inc.
  • ASCEND Therapeutics US LLC.
  • AbbVie Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Estrogen and Progesterone Replacement Therapy Market Sales by Geography (USD MN)
  • Human Growth Hormone (HGH) Replacement Therapy Market Sales by Geography (USD MN)
  • Thyroid Hormone Replacement Therapy Market Sales by Geography (USD MN)
  • Testosterone Replacement Therapy Market Sales by Geography (USD MN)
  • Parathyroid Hormone Replacement Market Sales by Geography (USD MN)
  • Analysis Market by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Parenteral Market Sales by Geography (USD MN)
  • Transdermal Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Disease Type (USD MN)
  • Menopause Market Sales by Geography (USD MN)
  • Hypothyroidism Market Sales by Geography (USD MN)
  • Male Hypogonadism Market Sales by Geography (USD MN)
  • Growth Hormone Deficiency Market Sales by Geography (USD MN)
  • Hypoparathyroidism Market Sales by Geography (USD MN)
  • Global Hormone Replacement Therapy Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Hormone Replacement Therapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Hormone Replacement Therapy Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Route Of Administration
  • Market Attractiveness Analysis by Disease Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Estrogen and Progesterone Replacement Therapy Market Sales by Geography (USD MN)
  • Human Growth Hormone (HGH) Replacement Therapy Market Sales by Geography (USD MN)
  • Thyroid Hormone Replacement Therapy Market Sales by Geography (USD MN)
  • Testosterone Replacement Therapy Market Sales by Geography (USD MN)
  • Parathyroid Hormone Replacement Market Sales by Geography (USD MN)
  • Global Market Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Parenteral Market Sales by Geography (USD MN)
  • Transdermal Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Disease Type (USD MN)
  • Menopause Market Sales by Geography (USD MN)
  • Hypothyroidism Market Sales by Geography (USD MN)
  • Male Hypogonadism Market Sales by Geography (USD MN)
  • Growth Hormone Deficiency Market Sales by Geography (USD MN)
  • Hypoparathyroidism Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11218811

The global demand for Hormone Replacement Therapy Market is presumed to reach the market size of nearly USD 45.55 BN by 2030 from USD 23.68 BN in 2022 with a CAGR of 8.52% under the study period 2023 - 2030.

Hormone replacement therapy (HRT) is a therapy used to treat women suffering from menopause issues. The harmones in such pateints are at inadequate levels compared to those required for the normal physiology of the human body. Hormone replacement therapy improves and extends the lives of many older women, whether initiated at menopause or much later. Hormone replacement therapy helps older women maintain their estrogen levels.

MARKET DYNAMICS:

A surge in menopausal discomfort and increased awareness about post-menopausal issues among women are expected to influence the hormone replacement therapy market growth to a great extent. The growth in the geriatric population is another reason for high demand of this therapy. Along with this, the launch of new hormone replacement therapy products is anticipated to drive market growth. Furthermore, the technological innovations in drug delivery systems could also positively impact the hormone replacement therapy market in the next few years. In addition, increased awareness about hormone replacement therapy is also expected to drive market growth. However, the high price associated with hormonal replacement therapy treatment may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hormone replacement therapy. The growth and trends of hormone replacement therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the hormone replacement therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Estrogen And Progesterone Replacement Therapy
  • Human Growth Hormone (HGH) Replacement Therapy
  • Thyroid Hormone Replacement Therapy
  • Testosterone Replacement Therapy
  • Parathyroid Hormone Replacement

By Route Of Administration

  • Oral
  • Parenteral
  • Transdermal
  • Others

By Disease Type

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Hypoparathyroidism

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Hormone Replacement Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hormone replacement therapy market include Bayer AG, Pfizer Inc., Merck & Co. Inc., Viatris Inc., Novo Nordisk A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Noven Pharmaceuticals Inc., ASCEND Therapeutics US LLC., AbbVie Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . HORMONE REPLACEMENT THERAPY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Route Of Administration
    • 3.7.3 Market Attractiveness Analysis By Disease Type
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Estrogen and Progesterone Replacement Therapy Historic and Forecast Sales by Regions
  • 6.5 Human Growth Hormone (HGH) Replacement Therapy Historic and Forecast Sales by Regions
  • 6.6 Thyroid Hormone Replacement Therapy Historic and Forecast Sales by Regions
  • 6.7 Testosterone Replacement Therapy Historic and Forecast Sales by Regions
  • 6.8 Parathyroid Hormone Replacement Historic and Forecast Sales by Regions

7 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 7.1 Overview by Route Of Administration
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Route Of Administration
  • 7.4 Oral Historic and Forecast Sales by Regions
  • 7.5 Parenteral Historic and Forecast Sales by Regions
  • 7.6 Transdermal Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET SALES ANALYSIS BY DISEASE TYPE

  • 8.1 Overview by Disease Type
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Disease Type
  • 8.4 Menopause Historic and Forecast Sales by Regions
  • 8.5 Hypothyroidism Historic and Forecast Sales by Regions
  • 8.6 Male Hypogonadism Historic and Forecast Sales by Regions
  • 8.7 Growth Hormone Deficiency Historic and Forecast Sales by Regions
  • 8.8 Hypoparathyroidism Historic and Forecast Sales by Regions

9 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HORMONE REPLACEMENT THERAPY COMPANIES

  • 10.1. Hormone Replacement Therapy Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF HORMONE REPLACEMENT THERAPY INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Bayer AG
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Pfizer Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Merck & Co. Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Viatris Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Novo Nordisk A/S
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Eli Lilly and Company
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. F. Hoffmann-La Roche Ltd
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Noven Pharmaceuticals Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. ASCEND Therapeutics US LLC.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. AbbVie Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies